scholarly article | Q13442814 |
P2093 | author name string | S Chandra | |
G W Kabalka | |||
M-L Yao | |||
S R Marepally | |||
P2860 | cites work | Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cells | Q31053697 |
The Chemistry of Neutron Capture Therapy | Q34114453 | ||
Boron neutron capture therapy of cancer: current status and future prospects | Q34423179 | ||
The radiation biology of boron neutron capture therapy | Q34491960 | ||
The synthesis and use of boronated amino acids for boron neutron capture therapy | Q36418029 | ||
Imaging intracellular elemental distribution and ion fluxes in cultured cells using ion microscopy: a freeze-fracture methodology. | Q36481590 | ||
Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer | Q40060823 | ||
Subcellular imaging by dynamic SIMS ion microscopy | Q40776293 | ||
Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro | Q40906700 | ||
Early history of development of boron neutron capture therapy of tumors | Q41470376 | ||
Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin | Q43549086 | ||
Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography | Q44199240 | ||
Unilamellar liposomes with enhanced boron content | Q44493506 | ||
The syntheses and in vivo biodistribution of novel boronated unnatural amino acids | Q45016254 | ||
An investigation of boron neutron capture therapy for recurrent glioblastoma multiforme | Q46735548 | ||
Uptake of two 10B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001). | Q46912762 | ||
Positron Emission Tomography (PET) with 1-Aminocyclobutane-1-[11C]carboxylic Acid (1-[11C]-ACBC) for Detecting Recurrent Brain Tumors | Q47597392 | ||
Blood-brain barrier transport of 1-aminocyclohexanecarboxylic acid, a nonmetabolizable amino acid for in vivo studies of brain transport | Q48092972 | ||
The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma | Q48309055 | ||
BNCT: Looking for a Few Good Molecules | Q48444469 | ||
Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10. | Q51337497 | ||
The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. | Q52593422 | ||
Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: Towards a novel therapy for liver metastases | Q59544249 | ||
Current status of 10B-neutron capture therapy: enhancement of tumor dose via beam filtration and dose rate, and the effects of these parameters on minimum boron content: a theoretical evaluation | Q70073429 | ||
Boron neutron capture therapy in the treatment of locally recurred head and neck cancer | Q80773195 | ||
P433 | issue | 7-8 Suppl | |
P304 | page(s) | S374-9 | |
P577 | publication date | 2009-04-02 | |
P1433 | published in | Applied Radiation and Isotopes | Q541448 |
P1476 | title | Biological evaluation of boronated unnatural amino acids as new boron carriers | |
P478 | volume | 67 |
Q38512169 | Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy |
Q34995062 | Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas |
Q89141802 | Boron delivery agents for neutron capture therapy of cancer |
Q38101622 | Boronated carbohydrate derivatives as potential boron neutron capture therapy reagents |
Q35103706 | Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy |
Q21203116 | Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer |
Q33728100 | Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas |
Q30475508 | Mass spectrometric imaging for biomedical tissue analysis |
Q26995529 | Mass spectrometry imaging and profiling of single cells |
Q35135541 | Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS). |
Search more.